Alnylam Pharmaceuticals (ALNY) Change in Taxes (2009 - 2010)
Alnylam Pharmaceuticals' (ALNY) quarterly Change in Taxes came in at $30000.0 in Q4 2010, down 99.31% on a YoY basis from $4.3 million in Q4 2009, and up 2900.0% quarter-over-quarter from $1000.0 in Q3 2010.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Change in Taxes (2009 - 2010) Analysis & Trends
Alnylam Pharmaceuticals (ALNY) has reported Change in Taxes for 2 consecutive years, with $30000.0 the latest figure, recorded in Q4 2010.
- For the quarter ending Q4 2010, Change in Taxes fell 99.31% year-over-year to $30000.0; the trailing twelve-month figure through Dec 2010 stood at -$5.5 million (changed N/A YoY), and the FY2010 full-year result was -$5.5 million, down 1081.16% from the prior year.
- Change in Taxes improved to $30000.0 in Q4 2010 per ALNY's latest filing, from $1000.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $4.3 million in Q4 2009 and bottomed at -$5.5 million in Q1 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | -131.00 Mn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 171.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 13.80 Mn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | -10.18 Mn |
| 10 | Insmed | 28.06 Bn | 26.90 Bn | 358.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2010 | 30,000.00 |
| Sep 30, 2010 | 1,000.00 |
| Jun 30, 2010 | -1,000.00 |
| Mar 31, 2010 | -5.55 Mn |
| Dec 31, 2009 | 4.33 Mn |
| Sep 30, 2009 | -512,000.00 |